Form 4 for AHR American Healthcare REIT, Inc.
Accepted 2025-03-17 00:00:00 ET · period of report 2025-03-14 · accession 0001941750-25-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-17 | 2025-03-14 | AHR | Foster Mark E. | EVP, GC, Sec | M - OptEx | — | +908 | 56.2K | +2% | — |
| D | 2025-03-17 | 2025-03-14 | AHR | Foster Mark E. | EVP, GC, Sec | F - Tax | $28.89 | -325 | 55.9K | -0.6% | -$9,389 |
| D | 2025-03-17 | 2025-03-14 | AHR | Foster Mark E. | EVP, GC, Sec | M - OptEx | $0.00 | -908 | 0 | -100% | $0 |
| D | 2025-03-17 | 2025-03-14 | AHR | Foster Mark E. | EVP, GC, Sec | A - Grant | $0.00 | +908 | 908 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-14 | M | A | 908 | — | 56,203 | D | — | — | (F1) Each restricted stock unit converts into one share of the Issuer's common stock. |
| 2 | Common | Common Stock | 2025-03-14 | F | D | 325 | $28.89 | 55,878 | D | — | — | (F2) Shares withheld by the Issuer to satisfy the Reporting Person's tax obligations associated with the vesting of performance-based restricted stock units on March 14, 2025. This is not an open market sale of securities. |
| 3 | Derivative | Restricted Stock Unit | 2025-03-14 | M | D | 908 | $0.00 | 0 | D | — · — to — | 908 Common Stock | (F1) Each restricted stock unit converts into one share of the Issuer's common stock. (F3) These performance-based restricted stock units ("PRSUs") were granted without cash consideration on August 8, 2022 under the Issuer's Second Amended and Restated 2015 Incentive Plan. The performance goals of such PRSUs were confirmed as having been met on March 14, 2025, on which date such PRSUs vested in full. |
| 4 | Derivative | Restricted Stock Unit | 2025-03-14 | A | A | 908 | $0.00 | 908 | D | — · — to — | 908 Common Stock | (F1) Each restricted stock unit converts into one share of the Issuer's common stock. (F3) These performance-based restricted stock units ("PRSUs") were granted without cash consideration on August 8, 2022 under the Issuer's Second Amended and Restated 2015 Incentive Plan. The performance goals of such PRSUs were confirmed as having been met on March 14, 2025, on which date such PRSUs vested in full. |